SE8104458L - Vattenloslig fraktion med formaga att reglera immunreaktioner hos ett verddjur gentemot allogena celler eller vevnad, farmaceutiska kompositioner, innehallande nemnda fraktion, samt sett att framstella sistnemnda - Google Patents

Vattenloslig fraktion med formaga att reglera immunreaktioner hos ett verddjur gentemot allogena celler eller vevnad, farmaceutiska kompositioner, innehallande nemnda fraktion, samt sett att framstella sistnemnda

Info

Publication number
SE8104458L
SE8104458L SE8104458A SE8104458A SE8104458L SE 8104458 L SE8104458 L SE 8104458L SE 8104458 A SE8104458 A SE 8104458A SE 8104458 A SE8104458 A SE 8104458A SE 8104458 L SE8104458 L SE 8104458L
Authority
SE
Sweden
Prior art keywords
cells
pct
tissue
pharmaceutical compositions
fraction
Prior art date
Application number
SE8104458A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
W Pierpaoli
G Maestroni
Original Assignee
Cell Eng Ag
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Eng Ag, Choay Sa filed Critical Cell Eng Ag
Publication of SE8104458L publication Critical patent/SE8104458L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8104458A 1979-11-22 1981-07-20 Vattenloslig fraktion med formaga att reglera immunreaktioner hos ett verddjur gentemot allogena celler eller vevnad, farmaceutiska kompositioner, innehallande nemnda fraktion, samt sett att framstella sistnemnda SE8104458L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7940392 1979-11-22

Publications (1)

Publication Number Publication Date
SE8104458L true SE8104458L (sv) 1981-07-20

Family

ID=10509350

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8104458A SE8104458L (sv) 1979-11-22 1981-07-20 Vattenloslig fraktion med formaga att reglera immunreaktioner hos ett verddjur gentemot allogena celler eller vevnad, farmaceutiska kompositioner, innehallande nemnda fraktion, samt sett att framstella sistnemnda

Country Status (9)

Country Link
US (1) US4540574A (fr)
JP (1) JPS56501525A (fr)
AU (1) AU544136B2 (fr)
CH (1) CH650154A5 (fr)
DK (1) DK312081A (fr)
FR (1) FR2469926A1 (fr)
GB (1) GB2074864B (fr)
SE (1) SE8104458L (fr)
WO (1) WO1981001367A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569110B1 (fr) * 1984-08-17 1987-09-25 Ionescu Pantelimon Dumitru Sang animal et moelle osseuse animale decancerisants, transfusibles aux hommes, procede et appareil pour leur preparation
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5482924A (en) * 1991-05-06 1996-01-09 Centre National De La Recherche Proteinaceous compositions having an activity on erythropoiesis
MD838G2 (ro) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
EP0673652B1 (fr) * 1992-07-21 2002-03-13 NIKOLAENKO; Alexandr, Nikolaevich Agent biologiquement actif ayant des proprietes d'immunomodulation, procede pour sa production et preparation pharmaceutique a base de cet agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1345565A (fr) * 1962-01-19 1963-12-13 Rolland Lab A Procédé pour l'obtention d'extraits totaux plus généralement orginaires de tissus viants
NL6405724A (fr) * 1963-05-23 1964-11-24
GB1086689A (en) * 1964-12-01 1967-10-11 Alkliam Chemicals Ltd Pharmaceutically active extracts of bone marrow
US3526697A (en) * 1966-10-06 1970-09-01 Nevada Pharm Inc Therapeutic method
FR2112112B1 (fr) * 1970-11-04 1974-09-20 Rusin Marina
US4136170A (en) * 1975-11-21 1979-01-23 Andre Thomas Method of extracting a hyperglycemic factor
DE2961660D1 (en) * 1978-05-03 1982-02-18 Yves Marie Frank Souron Wound-healing product extracted from animal bone marrow

Also Published As

Publication number Publication date
AU544136B2 (en) 1985-05-16
CH650154A5 (de) 1985-07-15
GB2074864B (en) 1984-08-22
DK312081A (da) 1981-07-13
FR2469926B1 (fr) 1983-12-30
US4540574A (en) 1985-09-10
GB2074864A (en) 1981-11-11
JPS56501525A (fr) 1981-10-22
AU6486980A (en) 1981-06-03
WO1981001367A1 (fr) 1981-05-28
FR2469926A1 (fr) 1981-05-29

Similar Documents

Publication Publication Date Title
Evans et al. The effects of recombinant human interleukin-1β on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone
JPS59192364A (ja) 軟骨および骨の修復方法
ATE256475T1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
CN105853292A (zh) 一种精华液、制备方法及应用
US20060099223A1 (en) Enzymetic hydrolysate of algae and method for preparing the same
DE60031307D1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
SE8104458L (sv) Vattenloslig fraktion med formaga att reglera immunreaktioner hos ett verddjur gentemot allogena celler eller vevnad, farmaceutiska kompositioner, innehallande nemnda fraktion, samt sett att framstella sistnemnda
Hanks Calcification of cell cultures in the presence of embryo juice and mammalian sera
CN107349220A (zh) 一种包含成纤维细胞外泌体的制剂及其用途
Schwemmler Endosymbionts: factors of egg pattern formation
CA2073453A1 (fr) Methodes de stimulation de la guerison des plaies et de la reparation des tissus
Kedar et al. In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes
PL301012A1 (en) Extract from bacterial macromolecules, method of preparing same and pharmaceutical composition containing it
Singh et al. Importance of OR potential in initiating cultures of axenically grown Entamoeba histolytica from small inocula
Maurizi et al. Morphological and functional characteristics of human temporal-bone cell cultures
KR100195571B1 (ko) 수산화아연/수산화칼슘 겔, 레시틴 및 폴리알파올레핀으로 처리된 항원용액 및 이의 제조방법
ES2168845T3 (es) Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos.
DE59310192D1 (de) Ligninpolymerzusammensetzung zur Behandlung von Hautproblemen
ES8201955A1 (es) Un procedimiento de produccion de derivados del acido 2-hi- droxioxanilico
Pedersen et al. Depressive effects of acrylic cement components on bone metabolism: isotope release and phosphatase production studied in vitro
EP0067382A3 (en) N-cyclohexyl-chloroacetamides, their preparation and their use in combating undesired plant growth
Urist Enzymes in bone morphogenesis: endogenous enzymic degradation of the morphogenetic property in bone in solutions buffered by ethylenediaminetetraacetic acid (EDTA)
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
IM et al. MODIFICATION OF GRAFT-VERSUS-HOST DISEASE BY NEURAMINIDASE TREATMENT OF DONOR CELLS DECREASED TOLEROGENICITY OF NEURAMINIDASE-TREATED CELLS
MATSUYAMA et al. Host origin of lymphoid cells in thymomas developed from subcutaneous thymus grafts in Buffalo rats

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8104458-8